Literature DB >> 28848872

COPD Overdiagnosis, Underdiagnosis, and Treatment.

Cristine E Berry1, Barbara P Yawn2.   

Abstract

This article serves as a CME-available enduring material summary of the following COPD9USA presentations: - "Spirometry Isn't for Screening - So What Is?" Presenter: David H. Au, MD, MS - "Diagnosis of COPD in a Primary Care Midwest Practice" Presenter: Barbara Yawn, MD, MSc - "What Happens in Primary Care Without Screening?" Presenter: Sandra G. Adams, MD, MS - "From Screening to Diagnosis to Management in a Busy Primary Care Practice"Presenter: Min Joo, MD - "Practical Considerations of How Phenotype and Genotype Can Affect Management Decisions" Presenter: Bartolome Celli, MD.

Entities:  

Keywords:  copd; lung function; primary care; screening; spirometry

Year:  2016        PMID: 28848872      PMCID: PMC5559132          DOI: 10.15326/jcopdf.3.1.2015.0172

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  16 in total

Review 1.  Uses and abuses of screening tests.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

2.  The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.

Authors:  Ciro Casanova; Juan P de Torres; Armando Aguirre-Jaíme; Victor Pinto-Plata; Jose M Marin; Elizabeth Cordoba; Rebeca Baz; Claudia Cote; Bartolome R Celli
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

3.  Effect of primary-care spirometry on the diagnosis and management of COPD.

Authors:  P P Walker; P Mitchell; F Diamantea; C J Warburton; L Davies
Journal:  Eur Respir J       Date:  2006-07-26       Impact factor: 16.671

4.  Cost-effectiveness of CT screening in the National Lung Screening Trial.

Authors:  William C Black; Ilana F Gareen; Samir S Soneji; JoRean D Sicks; Emmett B Keeler; Denise R Aberle; Arash Naeim; Timothy R Church; Gerard A Silvestri; Jeremy Gorelick; Constantine Gatsonis
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

5.  Attitudes and Perceptions About Smoking Cessation in the Context of Lung Cancer Screening.

Authors:  Steven B Zeliadt; Jaimee L Heffner; George Sayre; Deborah E Klein; Carol Simons; Jennifer Williams; Lynn F Reinke; David H Au
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

6.  Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD.

Authors:  Barbara P Yawn; Paul L Enright; Robert F Lemanske; Elliot Israel; Wilson Pace; Peter Wollan; Homer Boushey
Journal:  Chest       Date:  2007-06-05       Impact factor: 9.410

7.  Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial.

Authors:  Gary Parkes; Trisha Greenhalgh; Mark Griffin; Richard Dent
Journal:  BMJ       Date:  2008-03-06

8.  Bronchodilator responsiveness in patients with COPD.

Authors:  D P Tashkin; B Celli; M Decramer; D Liu; D Burkhart; C Cassino; S Kesten
Journal:  Eur Respir J       Date:  2008-02-06       Impact factor: 16.671

9.  Changes in forced expiratory volume in 1 second over time in COPD.

Authors:  Jørgen Vestbo; Lisa D Edwards; Paul D Scanlon; Julie C Yates; Alvar Agusti; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey O Coxson; Courtney Crim; David A Lomas; William MacNee; Bruce E Miller; Edwin K Silverman; Ruth Tal-Singer; Emiel Wouters; Stephen I Rennard
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

10.  Public knowledge of benefits of breast and prostate cancer screening in Europe.

Authors:  Gerd Gigerenzer; Jutta Mata; Ronald Frank
Journal:  J Natl Cancer Inst       Date:  2009-08-11       Impact factor: 13.506

View more
  1 in total

1.  The Impact of an Electronic Health Record Intervention on Spirometry Completion in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Christine Wang; Jonathan Siff; Peter J Greco; Edward Warren; J Daryl Thornton; Yasir Tarabichi
Journal:  COPD       Date:  2022       Impact factor: 2.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.